Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Why Everyone Should Be Screened for HCV and Treated If They Have It: Conversations Between Patient and Physician

This episode features a conversation between a patient, Shelley Rossell, and Norah Terrault, MD, MPH, who discuss the importance of universal HCV screening, the ease and benefits of DAA therapy, and how patients can be effective self-advocates for, during, and after treatment
Norah Terrault Headshot
Norah Terrault, MD, MPH
Released: May 3, 2022

In this episode, Norah Terrault, MD, MPH, and a patient who has been cured of hepatitis C virus (HCV) infection discuss the importance of universal HCV testing for all adults, as well as the ease of curative therapies and the benefits of living with improved liver function post cure.

This insightful discussion underscores how perceptions around HCV transmission risks and lack of symptoms serve as barriers to adequate screening and diagnosis, preventing curative treatment for many people with undiagnosed disease. The conversation also highlights the critical role of patient education and self-advocacy related to HCV infection, including what patients need to know and expect following cure.

Information on this Educational Activity


Norah Terrault, MD, MPH

Professor of Medicine
Chief of Gastrointestinal and Liver Diseases
University of Southern California
Los Angeles, California

Norah Terrault, MD, MPH, has disclosed that she has received funds for research support from Gilead Sciences, GlaxoSmithKline, and Roche/Genentech.

Program Medium

This program has been made available online.


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Gilead Sciences, Inc.

Related Content

Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who had end-stage liver failure from a missed HCV diagnosis

person default Sherry Tierney Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: May 17, 2022 Expired: May 16, 2023

Dr Dominique Braun discusses HCV in HIV-positive men who have sex with men (MSM) in the Swiss HIV Cohort Study, from Clinical Care Options (CCO)

Dominique Laurent Braun, MD Released: April 27, 2022

Clinical Care Options (CCO) audio: patient insights on overcoming barriers to HCV care for people with a history of injection drug use

Oluwaseun Falade-Nwulia, MBBS, MPH Released: April 20, 2022

Clinical Care Options (CCO) commentary from Oluwaseun Falade-Nwulia, MBBS, MPH, on the need for integrating HCV services into addiction medicine settings

Oluwaseun Falade-Nwulia, MBBS, MPH Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 30, 2022 Expired: March 29, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings